As the global economy grapples with the implications of an ageing population, the prospect of a growing market of consumers increasingly reliant on medication comes as welcome relief to a pharmaceuticals sector undergoing profound change.

The business of improving people's health may be booming as the rise in new and often chronic lifestyle-driven diseases, combined with higher expectations for better access and higher quality healthcare, present huge opportunities to those businesses with the right products.